Literature DB >> 18226613

Development of a screening tool for identifying women with menorrhagia for hemostatic evaluation.

Claire S Philipp1, Ambarina Faiz, Nicole F Dowling, Michele Beckman, Sally Owens, Charletta Ayers, Gloria Bachmann.   

Abstract

OBJECTIVE: A study was conducted to develop a short, easy to administer screening tool useful for stratifying women with unexplained menorrhagia for hemostatic testing for underlying bleeding disorders. STUDY
DESIGN: One hundred forty-six women with a physician diagnosis of menorrhagia underwent comprehensive hemostatic testing for the diagnosis of bleeding disorders, including von Willebrand disease, platelet dysfunction, and coagulation factor deficiencies. A 12 page questionnaire of bleeding symptoms was administered. Bleeding symptoms with high predictive values for laboratory hemostatic abnormalities were combined and used as single variables to calculate sensitivity, specificity, and positive and negative predictive values in order to develop a short screening tool to identify females for testing and evaluation.
RESULTS: A combination of 8 questions in 4 categories resulted in a sensitivity of 82% (95%CI 75-90) for bleeding disorders. Adding a pictorial blood assessment chart score > 100 increased the sensitivity of the screening tool to 95% (95%CI 91-99).
CONCLUSION: These results demonstrate the feasibility of a simple questionnaire based screening tool to identify females for testing and evaluation for bleeding disorders.

Entities:  

Mesh:

Year:  2008        PMID: 18226613     DOI: 10.1016/j.ajog.2007.08.070

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  18 in total

Review 1.  Evaluation and management of heavy menstrual bleeding in adolescents: the role of the hematologist.

Authors:  Sarah H O'Brien
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

2.  Acute uterine bleeding unrelated to pregnancy: a Southern California Permanente Medical Group practice guideline.

Authors:  Malcolm G Munro
Journal:  Perm J       Date:  2013

Review 3.  Abnormal Uterine Bleeding in Young Women with Blood Disorders.

Authors:  Kathryn E Dickerson; Neethu M Menon; Ayesha Zia
Journal:  Pediatr Clin North Am       Date:  2018-06       Impact factor: 3.278

Review 4.  The evolution and value of bleeding assessment tools.

Authors:  Natalia Rydz; Paula D James
Journal:  J Thromb Haemost       Date:  2012-11       Impact factor: 5.824

5.  Haemostatic Disorder in Women with Unexplained Menorrhagia: A Tertiary Care Centre Experience from Northern India.

Authors:  Rashmi Kushwaha; Ashutosh Kumar; Kusum Lata Mishra; Pushp Lata Sankhwar; Renu Singh
Journal:  J Clin Diagn Res       Date:  2017-05-01

6.  Evaluation of a screening tool for bleeding disorders in a US multisite cohort of women with menorrhagia.

Authors:  Claire S Philipp; Ambarina Faiz; John A Heit; Peter A Kouides; Andrea Lukes; Sidney F Stein; Vanessa Byams; Connie H Miller; Roshni Kulkarni
Journal:  Am J Obstet Gynecol       Date:  2011-01-17       Impact factor: 8.661

Review 7.  Heavy menstrual bleeding: work-up and management.

Authors:  Andra H James
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

8.  Evaluation of bleeding disorders in women with menorrhagia: a survey of obstetrician-gynecologists.

Authors:  Vanessa R Byams; Britta L Anderson; Althea M Grant; Hani Atrash; Jay Schulkin
Journal:  Am J Obstet Gynecol       Date:  2012-07-16       Impact factor: 8.661

9.  Significant gynecological bleeding in women with low von Willebrand factor levels.

Authors:  Michelle Lavin; Sonia Aguila; Niall Dalton; Margaret Nolan; Mary Byrne; Kevin Ryan; Barry White; Niamh M O'Connell; Jamie M O'Sullivan; Jorge Di Paola; Paula D James; James S O'Donnell
Journal:  Blood Adv       Date:  2018-07-24

10.  Utility of a screening tool for haemostatic defects in a multicentre cohort of adolescents with heavy menstrual bleeding.

Authors:  Ayesha Zia; Joseph Stanek; Myra Christian-Rancy; Sanjay P Ahuja; Stephanie Savelli; Sarah H O'Brien
Journal:  Haemophilia       Date:  2018-09-12       Impact factor: 4.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.